With black fungus cases rising in Uttarakhand, it was declared a notifiable disease in the state under the Epidemic Act, 1897 on Saturday.
So far, 64 people have been infected with black fungus in the state and of them, four have died.
Black fungus or mucormycosis has been declared a notifiable disease for its co-ordinated treatment as a growing number of people are contracting the infection post COVID-19, Health Secretary Pankaj Kumar Pandey said.
The state government also issued an SOP on Saturday for the judicious distribution of Amphotericin B, a drug used in treating black fungus patients.
Amphotericin B should be provided to only government medical colleges, institutions and Covid-dedicated hospitals on payment after they formally requisition for its supply on the prescribed format giving details of the patients and nature of infection.
Rashmi Pant and Kailash Gunjyal have been appointed as the nodal officers for scrutinising the requisitions for Kumaon and Garhwal regions respectively, the SOP said.
The current SOP supersedes an earlier order issued on May 18 for the judicious use of the drug, it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)